AXQ Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,574
Closed -$261K 674
2025
Q1
$261K Sell
1,574
-9,055
-85% -$1.42M 0.1% 335
2024
Q4
$1.54M Buy
+10,629
New +$1.65M 0.69% 14
2024
Q2
Sell
-6,700
Closed -$1.06M 584
2024
Q1
$1.06M Sell
6,700
-4,800
-42% -$764K 0.25% 135
2023
Q4
$1.8M Buy
+11,500
New +$1.76M 0.48% 28
2023
Q3
Sell
-2,300
Closed -$381K 534
2023
Q2
$381K Buy
+2,300
New +$371K 0.47% 71

Other funds holding JNJ

AXQ Capital's JNJ Position: Q2 2025 in Review

AXQ Capital sold out of Johnson & Johnson (JNJ) in Q2 2025, closing a stake of 1,574 shares — an estimated $261K sold.

AXQ Capital first reported a position in JNJ in Q2 2023 and held it in 5 quarters. The position peaked at $1.8M in Q4 2023. 4,082 funds tracked by Wall St. Rank hold JNJ as of Q2 2025.

  • AXQ Capital reported no remaining Johnson & Johnson position as of Q2 2025 after selling out during the quarter.
  • AXQ Capital sold 1,574 Johnson & Johnson shares in Q2 2025, an estimated $261K.
  • AXQ Capital first reported a position in Johnson & Johnson in Q2 2023 and held it in 5 quarters.
  • AXQ Capital's Johnson & Johnson position peaked at $1.8M in Q4 2023.
  • 4,082 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2025.

Based on AXQ Capital's 13F filing for Q2 2025, filed 12 Aug 2025.